FDA Approves Two New Indications and Dosage Form for Pembrolizumab

Autor:	Traci, DeVito, Naveed, Saleh
Rok vydání:	2019
Předmět:	Dosage Forms Antineoplastic Agents Immunological Lung Neoplasms United States Food and Drug Administration Carcinoma Non-Small-Cell Lung Humans Antibodies Monoclonal Humanized Carcinoma Renal Cell Drug Approval Kidney Neoplasms United States
Zdroj:	Oncology (Williston Park, N.Y.). 33(5)
ISSN:	0890-9091
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::a10c563d41408151655eceeb8f019616 https://pubmed.ncbi.nlm.nih.gov/31095718 Zobrazit plný text záznamu